RAPAMYCIN: CLINICAL RESULTS AND FUTURE OPPORTUNITIES1

This publication has 78 references indexed in Scilit:

• Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression
  Clinical Biochemistry, 1998
• Rapamycin Inhibition of the G1 to S Transition Is Mediated by Effects on Cyclin D1 mRNA and Protein Stability
  Journal of Biological Chemistry, 1998
• The Upregulation of p27Kip1 by Rapamycin Results in G1 Arrest in Exponentially Growing T-Cell Lines
  Blood, 1998
• Rapamycin Resistance Tied to Defective Regulation of p27^Kip1
  Molecular and Cellular Biology, 1996
• Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface
  Chemistry & Biology, 1995
• RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs
  Cell, 1994
• Rapamycin Inhibits p34^cdc2 Expression and Arrests T Lymphocyte Proliferation at the G1/S Transition
  Annals of the New York Academy of Sciences, 1993
• CYCLOSPORINE AND RAPAMYCIN AFFECT PROTEIN KINASE C INDUCTION OF THE INTRACELLULAR ACTIVATION SIGNAL, ACTIVATOR OF DNA REPLICATION
  Transplantation, 1993
• Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase
  Nature, 1992
• Atomic Structure of FKBP-FK506, an Immunophilin-Immunosuppressant Complex
  Science, 1991